Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Butyric acid wikipedia , lookup
Microbial metabolism wikipedia , lookup
Epitranscriptome wikipedia , lookup
NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup
Fatty acid synthesis wikipedia , lookup
Biochemistry wikipedia , lookup
Glyceroneogenesis wikipedia , lookup
Lactate dehydrogenase wikipedia , lookup
Fatty acid metabolism wikipedia , lookup
Citric acid cycle wikipedia , lookup
Metabolism of xenobiotics Seminar No. 8 1 Q. 2 2 1. Phase of biotransformation = mainly oxidations Reaction Xenobiotic (example) Hydroxylation aromatic hydrocarbons Sulfooxidation oxidations disulfides (R-S-R) Dehydrogenation alcohols Reduction nitro compounds (R-NO2) Hydrolysis esters Reactions occur mainly in ER, some in cytosol 3 Q. 3 4 A. 3 2H NADPH + H + FAD + Fe ++ hem RH O2 NADP + FADH2 cyt. reduktasa Fe +++ hem R OH H2O cyt P-450 The system of cytochrome P-450 is composed from: • two enzymes (cytochrome reductase, cytochrome P-450) • three cofactors (NADPH, FAD, hem) • in ER, mitochondria 5 Q. 4 + 5 R-H + O2 + 6 A. 4 + 5 Hydroxylation R-H + O2 + NADPH + H+ R-OH + H2O + NADP+ • substrate R-H reacts with O2 • monooxygenase = from O2 one atom O is inserted into substrate (between carbon and hydrogen atom) • the second O atom makes H2O, 2H come from NADPH+H+ • dioxygen is reduced to -OH group and water 7 Q. 6 8 A. 6 • Inducer may act on several levels: • Inducer in complex with intracellular receptor enters nucleus and binds to DNA enhances the transcription of mRNA • Decreases the degradation of mRNA and/or CYP • Influences the poststranscription modifications of mRNA • May cause the hypertrophy of ER 9 Influence of CYP inducers/inhibitors on the effect of drug (remedy) CYP inducer no interference insufficient effect of applied drug normal (expected) effect of remedy CYP inhibitor higher levels of drug unwanted effects overdosing optimal therapy 10 Q. 7 11 A. 7 • if concurrently aplied inducer + medicament metabolized with the same CYP isoform remedy is catabolized faster is less effective • diclofenac is less effective 12 Q. 8 13 A. 8 • if concurrently aplied inhibitor + medicament metabolized with the same CYP isoform remedy is catabolized more slowly higher concentration in blood adverse effects (overdosing) 14 Q. 9 15 A. 9 - II. Phase of biotransformation • conjugation – synthetic character • xenobiotic after I. phase reacts with conjugation reagent • the product is more polar – easily excreated by urine • conjugation reactions are endergonnic – they require energy • reagent or xenobiotic has to be activated 16 A. 9 Overview of conjugation reactions Conjugation Reagent Group in xenobiotic Glucuronidation -OH, -COOH, -NH2 Sulfatation -OH, -NH2, -SH Methylation -OH, -NH2 Acetylation -OH, -NH2 By GSH Ar-halogen By amino acid -COOH 17 A. 9 Overview of conjugation reactions Conjugation Reagent Group in xenobiotic Glucuronidation UDP-glucuronate -OH, -COOH, -NH2 Sulfatation PAPS -OH, -NH2, -SH Methylation SAM -OH, -NH2 Acetylation acetyl-CoA -OH, -NH2 By GSH glutathione Ar-halogen By amino acid glycine, taurine -COOH GSH = glutathione, PAPS = phosphoadenosine phosphosulfate SAM = S-adenosyl methionine 18 PAPS is sulfatation reagent phospho adenosine phospho sulfate NH2 O O O S N N O O O P N N O O O O P O O OH 19 The conjugation reactions of phenol hydroxylace hydroxylation (CYP 450) H OH konjugace conjugation glucuronide O glukuronát sulfate O sulfát 20 Glutathione (GSH) NH2 HOOC H O N N O CH2 COOH H SH R-X + GSH R-SG + XH R-X halogen alkanes (arenes) 21 Conjugation with aminoacids • glycine, taurine • xenobiotics with -COOH groups • the products of conjugation are amides • endogenous substrates – bile acids 22 Biotransformation of toluene (sniffers) CH3 CH2OH toluen toluene COOH benzylalkohol benzyl alcohol O benzoová kys. benzoic acid O glycin glycine C C OH benzoová kys. benzoic acid O NH CH2 C hippuric acid hippurová kyselina (N-benzoylglycin) (N-benzoylglycine) OH 23 Ethanol How can you calculate the level of alcohol in blood? 24 Per milles of alcohol in blood ‰ = per mille = 1/1000 malcohol (g) alcohol in blood (‰) = mbody (kg) f How do you calculate malcohol ? 0.67 (males) 0.55 (females) 25 malcohol is calculated from volume and density malc (g) = Valc (ml) × 0.8 (g/ml) density volume of pure alcohol is calculated from volume fraction beer 3-6 % wine 6-12 % liquors 40-50 % 26 Metabolism of ethanol Enzyme Subcellular localization Alcohol dehydrogenase (AD) cytosol MEOS endoplasmic reticulum (ER) Catalase (hem) peroxisome Acetaldehyde dehydrogenase cytosol / mitochondria 27 Write AD and AcD reactions 28 alkoholdehydrogenasa alcohol dehydrogenase (AD) H H H3C C O + NAD H3C C H O + NADH+ H H acetaldehyd acetaldehyde aldehyddehydrogenasa acetaldehyd dehydrogenase (AcD) H H3C C O + H2O H H H3C C O OH aldehyd-hydrát acetaldehyde hydrate NAD - 2H H3C C O OH acetic acid octová kyselina 29 Alternative pathway of alcohol biotransformation occurs in endoplasmic reticulum MEOS (microsomal ethanol oxidizing system, CYP2E1) CH3-CH2-OH + O2 + NADPH+H+ CH3-CH=O + 2 H2O + NADP+ activated at higher consumption of alcohol = higher blood level of alcohol (> 0.5 ‰) - chronic alcoholics increased production of acetaldehyde 30 Q. 11 31 A. 11 Acetate is converted to acetyl-CoA A) in liver synthesis of FA TAG VLDL B) in other tissues CAC CO2 + energy 32 A. 13 Mr = 46 density = 0,8 g/ml 1 (mmol) 0,046 (g) 0,058 (ml) 1 ml 0,058 1 (l) 1 (l) 1 (l) 1000 ml 0,06 ‰ 33 Q. 14 Metab. feature Change Explanation NADH/NAD+ Lactate/pyruvate CAC Glycolysis Gluconeogenesis 34 A. 14 Metab. feature Change Explanation NADH/NAD+ NADH overproduction in AD/AcD reactions Lactate/pyruvate NADH excess in cytosol in removed by LD reaction CAC NADH is allost. inhibitor of ICDH and 2-OGDH Glycolysis shortage of NAD+ Gluconeogenesis shortage of pyruvate + OA (= predominate lactate + malate) 35 Q. 15 36 A. 15 A) Decreased gluconeogenesis due to lack of oxaloacetate – hypoglycemia especially after fasting ingestion of alcohol (+ usually poor dietary habits in chronic alcoholics) B) Excess of lactate in cytosol increased lactate in blood plasma lactic acidosis C) Excess of acetyl-CoA synthesis of FA +TAG liver steatosis 37 Consider that ! • ethanol is soluble both in polar water and non-polar lipids • easily penetrates cell membranes • goes through hydrophilic protein channels or pores • as well as hydrophobic phospholipid bilayer 38 Metabolic consequences of EtOH biotransformation Ethanol ADH ADH MEOS part. soluble in membrane PL acetaldehyde (hangover) excess of NADH in cytosol reoxidation by pyruvate adducts with proteins, NA, biog. amines toxic effects on CNS acetate lactic acidosis acetyl-CoA hypoglycaemia various products FA/TAG synth. liver steatosis 39 Acetaldehyde reacts with biogenic amines to tetrahydroisoquinoline derivatives HO HO NH2 HO dopamine H C O CH3 acetaldehyde - H2O HO N H CH3 salsolinol 6,7-dihydroxy-1-methyl-1,2,3,4tetrahydroisoquinoline Neurotoxin ? 40 Nicotine - the main alkaloid of tobacco On cigarette box: N N Nicotine: 0.9 mg/cig. CH3 Tar: 11 mg/cig. 3-(1-methylpyrrolidin-2-yl)pyridine 41 Cigarette smoke contains a number of different compounds • free nicotine – binds to nicotine receptors in brain and other tissues • CO – binds to hemoglobin carbonylhemoglobin • nitrogen oxides – can generate free radicals • polycyclic aromatic hydrocarbons (PAH) (pyrene, chrysene), main components of tar, attack and damage DNA, carcinogens • other substances (N2, CO2, HCN, CH4, terpenes, esters …) 42 Example Biotransformation of nicotine N CH3 N nikotin nicotine N OH N N H CH3 N 5-hydroxynikotin 5-hydroxynicotine nornikotin nornicotine nikotin-N-glukuronát nicotine-N-glucuronide N cotinine-N-glucuronide kotinin-N-glukuronát N O CH3 kotinin cotinine 43 Biochemical markers of liver diseases Liver function / condition Biochemical marker Integrity of hepatocyte membrane Necrosis of liver Bile excretion Proteosynthesis disorder Detoxification functions Disorder of AA metabolism Disorder of glucose metabolism Disorder of lipid metabolism 44 Biochemical markers of liver diseases Liver function / condition Biochemical marker Integrity of hepatocyte membrane ALT, GMT, ALP Necrosis of liver AST, GMD Bile excretion ALP, bilirubin, bile ac., urobilinogen Proteosynthesis disorder (pre)albumin, CHS, coag. factors Detoxification functions caffeine test (p.o.) – metabolites in urine Disorder of AA metabolism urea, NH4+ Disorder of glucose metabolism glucose Disorder of lipid metabolism TAG, HDL 45 Selected biochem. markers of liver damage (in serum) Serum analyte Reference values ALT 0,1 - 0,8 kat/l GMD 0,1 - 0,7 kat/l GMT 0,1 - 0,7 kat/l Bilirubin 5 - 20 mol/l Ammonia 5 - 50 mol/l Urobilinogens (urine) up to 17 mol/l ------------------------------ --------------------- Change ------------- Pseudocholinesterase 65 - 200 kat/l Urea 3 - 8 mmol/l Albumin 35 - 53 g/l 46